Obesity / Weight Management · Currently recruiting
CagriSema (REDEFINE program)
Investigational fixed-dose combination of cagrilintide and semaglutide for chronic weight management, evaluating efficacy and safety in adults with overweight or obesity.
Study details
Condition: Obesity / Weight Management
Status: Recruiting
Registry: NCT07564414 on ClinicalTrials.gov
Site: EndoTrials Clinical Research Center, La Mesa, California
Full eligibility criteria are set by the study protocol and listed in the registry entry above. Our research team will review them with you, explain what participation involves, including visits, procedures and compensation where applicable, and answer your questions before you decide. Participation is voluntary, and you can withdraw at any time.
EndoTrials is the clinical research center of Diabetes & Endocrine Specialists, led by Darius A. Schneider, MD, PhD.